1. Polygonumins A, a Newly Isolated Compound from the Stem of Polygonum minus Huds with Potential Medicinal Activities. Ahmad, R., I. Sahidin, M. Taher, C.F. Low, N.M. Noor, C. Sillapachaiyaporn, S. Chuchawankul, T. Sarachana, T. Tencomnao, F. Iskandar, N.F. Rajab, and S.N. Baharum. Scientific Reports, 2018. 8(4202): 15pp. PMID[29523802]. PMCID[PMC5845017].
[PubMed]. HIV_03_2018.
2. Chemical Constituents of Bryophytes: Structures and Biological Activity. Asakawa, Y. and A. Ludwiczuk. Journal of Natural Products, 2018. 81(3): p. 641-660. PMID[29019405].
[PubMed]. HIV_03_2018.
3. Targeting a Dark Excited State of HIV-1 Nucleocapsid by Antiretroviral Thioesters Revealed by NMR Spectroscopy. Deshmukh, L., V. Tugarinov, D.H. Appella, and G.M. Clore. Angewandte Chemie, 2018. 57(10): p. 2687-2691. PMID[29345807].
[PubMed]. HIV_03_2018.
4. Chemical Composition of Essential Oils from Thymus vulgaris, Cymbopogon citratus, and Rosmarinus officinalis, and their Effects on the HIV-1 Tat Protein Function. Feriotto, G., N. Marchetti, V. Costa, S. Beninati, F. Tagliati, and C. Mischiati. Chemistry & Biodiversity, 2018. 15(2).p. e1700436.PMID[29282856].
[PubMed]. HIV_03_2018.
5. In Silico Screening for Human Norovirus Antivirals Reveals a Novel non-Nucleoside Inhibitor of the Viral Polymerase. Ferla, S., N.E. Netzler, S. Ferla, S. Veronese, D.E. Tuipulotu, S. Guccione, A. Brancale, P.A. White, and M. Bassetto. Scientific Reports, 2018. 8(4129): 18pp. PMID[29515206]. PMCID[PMC5841303].
[PubMed]. HIV_03_2018.
6. RNA glycosidase and Other Agents Target Tat to Inhibit HIV-1 Transcription. Harrich, D. and H. Jin. The Biochemical Journal, 2018. 475(6): p. 1059-1062. PMID[29559581].
[PubMed]. HIV_03_2018.
7. Identification of a CD4-binding-site Antibody to HIV That Evolved near-Pan Neutralization Breadth. Huang, J., B.H. Kang, E. Ishida, T. Zhou, T. Griesman, Z. Sheng, F. Wu, N.A. Doria-Rose, B. Zhang, K. McKee, S. O'Dell, G.Y. Chuang, A. Druz, I.S. Georgiev, C.A. Schramm, A. Zheng, M.G. Joyce, M. Asokan, A. Ransier, S. Darko, S.A. Migueles, R.T. Bailer, M.K. Louder, S.M. Alam, R. Parks, G. Kelsoe, T. Von Holle, B.F. Haynes, D.C. Douek, V. Hirsch, M.S. Seaman, L. Shapiro, J.R. Mascola, P.D. Kwong, and M. Connors. Immunity, 2016. 45(5): p. 1108-1121. PMID[27851912]. PMCID[PMC5770152].
[PubMed]. HIV_03_2018.
8. Identification of Bichalcones as Sirtuin Inhibitors by Virtual Screening and in Vitro Testing. Karaman, B., Z. Alhalabi, S. Swyter, S.O. Mihigo, K. Andrae-Marobela, M. Jung, W. Sippl, and F. Ntie-Kang. Molecules, 2018. 23(2): p. E416. PMID[29443909].
[PubMed]. HIV_03_2018.
9. A Novel Peptide Shows Excellent anti-HIV-1 Potency as a gp41 Fusion Inhibitor. Liu, W., X. An, J. Wang, X. Zhang, J. Tan, Z. Zhou, and Y. Zeng. Bioorganic & Medicinal Chemistry Letters, 2018. 28(5): p. 910-914. PMID[29433929].
[PubMed]. HIV_03_2018.
10. Structural Optimization of N-1-Aryl-benzimidazoles for the Discovery of New Non-Nucleoside Reverse Transcriptase Inhibitors Active against Wild-type and Mutant HIV-1 Strains. Monforte, A.M., L.L. De, M.R. Buemi, F.E. Agharbaoui, C. Pannecouque, and S. Ferro. Bioorganic & Medicinal Chemistry, 2018. 26(3): p. 661-674. PMID[29291935].
[PubMed]. HIV_03_2018.
11. Uvaria angolensis as a Promising Source of Inhibitors of HIV-1 RT-associated RNA-dependent DNA Polymerase and RNase H Functions. Ngoutane Mfopa, A., A. Corona, K. Eloh, E. Tramontano, A. Frau, F.F. Boyom, P. Caboni, and G. Tocco. Natural Product Research, 2018. 32(6): p. 640-647. PMID[28540745].
[PubMed]. HIV_03_2018.
12. Anti-HIV Activity of New Higher Order G-quadruplex Aptamers Obtained from Tetra-end-linked Oligonucleotides. Nici, F., G. Oliviero, A.P. Falanga, S. D'Errico, M. Marzano, D. Musumeci, D. Montesarchio, S. Noppen, C. Pannecouque, G. Piccialli, and N. Borbone. Organic & Biomolecular Chemistry, 2018. 16(13): p. 2349-2355. PMID[29543291].
[PubMed]. HIV_03_2018.
13. Anti-HIV and Cytotoxic Biphenyls, Benzophenones and Xanthones from Stems, Leaves and Twigs of Garcinia speciosa. Pailee, P., C. Kuhakarn, C. Sangsuwan, S. Hongthong, P. Piyachaturawat, K. Suksen, S. Jariyawat, R. Akkarawongsapat, J. Limthongkul, C. Napaswad, P. Kongsaeree, S. Prabpai, T. Jaipetch, M. Pohmakotr, P. Tuchinda, and V. Reutrakul. Phytochemistry, 2018. 147: p. 68-79. PMID[29304383].
[PubMed]. HIV_03_2018.
14. Restricted HIV-1 Env Glycan Engagement by Lectin-reengineered DAVEI Protein Chimera is Sufficient for Lytic Inactivation of the Virus. Parajuli, B., K. Acharya, H.C. Bach, B. Parajuli, S. Zhang, A.B. Smith, 3rd, C.F. Abrams, and I. Chaiken. Biochemical Journal, 2018. 475(5): p. 931-957. PMID[29343613].
[PubMed]. HIV_03_2018.
15. Synthesis of Novel 3-(5-(Alkyl/Arylthio)-1,3,4-oxadiazol-2-yl)-8-phenylquinolin-4(1H)-one Derivatives as anti-HIV Agents.Parizadeh, N., E. Alipour, S. Soleymani, R. Zabihollahi, M.R. Aghasadeghi, Z. Hajimahdi, and A. Zarghi. Phosphorus Sulfur and Silicon and the Related Elements, 2018. 193(4): p. 225-231. ISI[000426940800005].
[WOS]. HIV_03_2018.
16. Ellagic acid Inhibits HIV-1 Infection in Vitro: Potential Role as a Novel Microbicide. Promsong, A., T. Chuenchitra, K. Saipin, S. Tewtrakul, P. Panichayupakaranant, S. Satthakarn, and W. Nittayananta. Oral Diseases, 2018. 24(1-2): p. 249-252. PMID[29480632].
[PubMed]. HIV_03_2018.
17. The Oncolytic Virus MG1 Targets and Eliminates Cells Latently Infected with HIV-1: Implications for an HIV Cure.Ranganath, N., T.S. Sandstrom, S.C.B. Schinkel, S.C. Cote, and J.B. Angel. Journal of Infectious Diseases, 2018. 217(5): p. 721-730. PMID[29228368].
[PubMed]. HIV_03_2018.
18. Pharmacokinetic and Chemical Synthesis Optimization of a Potent D-Peptide HIV Entry Inhibitor Suitable for Extended-release Delivery. Redman, J.S., J.N. Francis, R. Marquardt, D. Papac, A.L. Mueller, D.M. Eckert, B.D. Welch, and M.S. Kay. Molecular Pharmaceutics, 2018. 15(3): p. 1169-1179. PMID[29436835].
[PubMed]. HIV_03_2018.
19. New Findings on the d(TGGGAG) Sequence: Surprising anti-HIV-1 Activity.Romanucci, V., A. Zarrelli, S. Liekens, S. Noppen, C. Pannecouque, and F.G. Di. European Journal of Medicinal Chemistry, 2018. 145: p. 425-430. PMID[29335208].
[PubMed]. HIV_03_2018.
20. Prenylated Phloroglucinols from Hypericum scruglii, an Endemic Species of Sardinia (Italy), as New Dual HIV-1 Inhibitors Effective on HIV-1 Replication. Sanna, C., M. Scognamiglio, A. Fiorentino, A. Corona, V. Graziani, A. Caredda, P. Cortis, M. Montisci, E.R. Ceresola, F. Canducci, F. Poli, E. Tramontano, and F. Esposito. Plos One, 2018. 13(3): p. e0195168. PMID[29601601].
[PubMed].HIV_03_2018.
21. Synthesis of Tetracyclic Azasugars Fused Benzo[e][1,3]thiazin-4-one by the Tandem Staudinger/Aza-Wittig/Cyclization and Their HIV-RT Inhibitory Activity. Shao, J., M. Zhu, L.G. Gao, H. Chen, and X.L. Li. Carbohydrate Research, 2018. 456: p. 45-52. PMID[29274552].
[PubMed]. HIV_03_2018.
22. Rational Design of a Trispecific Antibody Targeting the HIV-1 Env with Elevated anti-Viral Activity.Steinhardt, J.J., J. Guenaga, H.L. Turner, K. McKee, M.K. Louder, S. O'Dell, C.I. Chiang, L. Lei, A. Galkin, A.K. Andrianov, N.A. Doria-Rose, R.T. Bailer, A.B. Ward, J.R. Mascola, and Y.X. Li. Nature Communications, 2018. 9(877): 12pp. PMID[29491415]. PMCID[PMC5830440].
[PubMed]. HIV_03_2018.
23. Defining the Distinct, Intrinsic Properties of the Novel Type I Interferon, IFN Epsilon. Stifter, S.A., A.Y. Matthews, N.E. Mangan, K.Y. Fung, A. Drew, M.D. Tate, C.T.P.S. da, D. Hampsey, J. Mayall, P.M. Hansbro, A.G. Minambres, S.G. Eid, J. Mak, J. Scoble, G. Lovrecz, N.A. deWeerd, and P.J. Hertzog. Journal of Biological Chemistry, 2018. 293(9): p. 3168-3179. ISI[000426562800012].
[WOS]. HIV_03_2018.
24. Structural Insights into the Mechanisms of Action of Short-peptide HIV-1 Fusion Inhibitors Targeting the gp41 Pocket. Zhang, X.J., Y.M. Zhu, H. Hu, S.Y. Zhang, P.F. Wang, H.H. Chong, J.S. He, X.Q. Wang, and Y.X. He. Frontiers in Cellular and Infection Microbiology, 2018. 8(51): 13pp. PMID[29535974]. PMCID[PMC5834435].
[PubMed]. HIV_03_2018.
Patent Citations
25. Preparation of Dihydroxypyridinylpyrimidinecarboxamide Derivatives for Use as HIV-1 Nucleocapsid Inhibitors. Botta, M., M. Mori, F. Saladini, M. Zazzi, P. Fezzardi, S. Harper, S. Malancona, M. Santoriello, V. Summa, D. De Forni, L. Kovalenko, Y. Mely, M. Pires, E. Real, S. Lyonnais, and G. Mirambeau. Patent. 2018. 2016-186511 3290412: 51pp.
[Patent]. HIV_03_2018.
26. Preparation of Cyclic Peptides as Antiviral Agents. Chaiken, I.M. and A.A.R. Ahmed. Patent. 2018. 2017-US51380 2018053013: 92pp.
[Patent]. HIV_03_2018.
27. Antiviral Prodrugs of Tenofovir. Da Costa, D., C.B. Dousson, D. Dukhan, J.-L. Paparin, H. Rahali, and I. Raheem. Patent. 2018. 2017-US47892 2018039157: 75pp.
[Patent]. HIV_03_2018.
28. Preparation of Miliusanes as Antiviral Agents. Zhang, H. Patent. 2018. 2017-15802534 20180065946: 41pp , Cont -in-part of U S Ser No 610,926.
[Patent]. HIV_03_2018.
29. Treatment and Prevention of Viral Infection Using Nuclear Receptor Agonists. Zhuang, X. and J.A. McKeating. Patent. 2018. 2017-GB52575 2018042207: 42pp.
[Patent]. HIV_03_2018.